Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
Kale KundertJames E LucasKyle E WattersChristof FellmannAndrew H NgBenjamin M HeineikeChristina M FitzsimmonsBenjamin L OakesJiuxin QuNeha PrasadOren S RosenbergDavid F SavageHana El-SamadJennifer A DoudnaTanja KortemmePublished in: Nature communications (2019)
The CRISPR-Cas9 system provides the ability to edit, repress, activate, or mark any gene (or DNA element) by pairing of a programmable single guide RNA (sgRNA) with a complementary sequence on the DNA target. Here we present a new method for small-molecule control of CRISPR-Cas9 function through insertion of RNA aptamers into the sgRNA. We show that CRISPR-Cas9-based gene repression (CRISPRi) can be either activated or deactivated in a dose-dependent fashion over a >10-fold dynamic range in response to two different small-molecule ligands. Since our system acts directly on each target-specific sgRNA, it enables new applications that require differential and opposing temporal control of multiple genes.